Some of China’s senior doctors are raising concern over the quality of domestic generic medicines that have largely replaced Western brand-name drugs at hospitals, amid a rare public backlash against the government’s drive to cut medical costs.
Hospital chiefs and doctors in Beijing and Shanghai said the cheaper generic drugs mandated for use at public hospitals do not appear to have the same efficacy or side effects as drugs from major international pharmaceutical companies, local media Caixin and China Business News reported over the weekend.
They fear their widespread use risks breeding mistrust among doctors and patients.
Photo: AP
In a proposal to the ongoing annual local parliamentary session, doctors suggest greater flexibility in the nation’s drug-contract bidding process so that doctors and patients can have the choice to switch back to Western brand-name drugs when they want to, local media reported.
The complaints from frontline doctors have prompted the National Healthcare Security Administration, which oversees China’s state medical insurance scheme, to look into the issue.
The agency is to meet with doctors and experts in Shanghai this week to learn more about their advice and collect more clinical data on domestic generic medicines, a statement published on its Web site yesterday said.
Zheng Minhua, a senior surgeon at Shanghai’s prestigious Ruijin Hospital, cited in an interview with Caixin examples of how domestic generic medicines failed to work properly, such as not being able to control hypertension effectively or anesthetics not being able to put patients to sleep.
Since it was launched six years ago, the government’s drug bidding process, known as volume-based procurement, has seen off-patent medicines from global pharmaceutical giants such as AstraZeneca PLC and Pfizer Inc replaced by similar drugs made by domestic companies, often sold at a fraction of the price.
The program has saved Beijing billions of US dollars over the years, which it has then used to reimburse higher-value innovative therapies, including many blockbusters developed by Western drugmakers.
From 2018 to 2023, makers of generic drugs slashed prices by more than 50 percent on average to win contracts, with some cutting as much as 90 percent.
In the most recent round of procurement, the winning bids for generic aspirin tablets were as low as 0.03 yuan (US$0.0041) per pill, while folic acid tablets for pregnant women could be available for just 0.0289 yuan each.
While domestic generics supplied to Chinese hospitals have passed bioequivalence tests that show they work as well as the brand-name medicines, there has been growing chatter among patients and doctors since last year that the quality of these drugs does not quite measure up to the Western ones.
China is set to push for a new procurement round later this year. The rare backlash from doctors is raising questions whether Beijing’s bid to cut drug prices might have come at the expense of quality and might end up fomenting public discontent.
‘DISCRIMINATION’: The US Office of Personnel Management ordered that public DEI-focused Web pages be taken down, while training and contracts were canceled US President Donald Trump’s administration on Tuesday moved to end affirmative action in federal contracting and directed that all federal diversity, equity and inclusion (DEI) staff be put on paid leave and eventually be laid off. The moves follow an executive order Trump signed on his first day ordering a sweeping dismantling of the federal government’s diversity and inclusion programs. Trump has called the programs “discrimination” and called to restore “merit-based” hiring. The executive order on affirmative action revokes an order issued by former US president Lyndon Johnson, and curtails DEI programs by federal contractors and grant recipients. It is using one of the
One of Japan’s biggest pop stars and best-known TV hosts, Masahiro Nakai, yesterday announced his retirement over sexual misconduct allegations, reports said, in the latest scandal to rock Japan’s entertainment industry. Nakai’s announcement came after now-defunct boy band empire Johnny & Associates admitted in 2023 that its late founder, Johnny Kitagawa, for decades sexually assaulted teenage boys and young men. Nakai was a member of the now-disbanded SMAP — part of Johnny & Associates’s lucrative stable — that swept the charts in Japan and across Asia during the band’s nearly 30 years of fame. Reports emerged last month that Nakai, 52, who since
EYEING A SOLUTION: In unusually critical remarks about Russian President Vladimir Putin, US President Donald Trump said he was ‘destroying Russia by not making a deal’ US President Donald Trump on Wednesday stepped up the pressure on Russian President Vladimir Putin to make a peace deal with Ukraine, threatening tougher economic measures if Moscow does not agree to end the war. Trump’s warning in a social media post came as the Republican seeks a quick solution to a grinding conflict that he had promised to end before even starting his second term. “If we don’t make a ‘deal,’ and soon, I have no other choice but to put high levels of Taxes, Tariffs, and Sanctions on anything being sold by Russia to the United States, and various other
In Earth’s upper atmosphere, a fast-moving band of air called the jet stream blows with winds of more than 442kph, but they are not the strongest in our solar system. The comparable high-altitude winds on Neptune reach about 2,000kph. However, those are a mere breeze compared with the jet stream on a planet called WASP-127b. Astronomers have detected winds howling at about 33,000kph on the large gaseous planet in our Milky Way galaxy approximately 520 light-years from Earth in a tight orbit around a star similar to our sun. The supersonic jet-stream winds circling WASP-127b at its equator are the fastest of their kind
RSS